Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DE:TEV
Stock Latest News
The Fly
Unusually active option classes on open February 24th
23h ago
F
HD
Premium
The Fly
FDA accepts Teva NDA for olanzapine extended-release injectable suspension
5d ago
TEVA
Premium
The Fly
Teva management to meet with Piper Sandler
5d ago
TEVA
Premium
The Fly
Corcept Therapeutics price target lowered to $67 from $105 at H.C. Wainwright
5d ago
CORT
TEVA
Premium
The Fly
Corcept ‘disappointed’ in court ruling over Teva patent dispute
6d ago
CORT
TEVA
Premium
The Fly
Midday Fly By: Walmart reports Q4 beat, eBay to acquire Depop from Etsy
6d ago
DE
VZ
Premium
The Fly
Corcept Therapeutics down 18% after appeals court ruling in Teva fight
6d ago
CORT
TEVA
Premium
The Fly
Teva price target raised to $38 from $37 at BofA
7d ago
SNY
TEVA
Premium
Ratings
Teva Buy Rating Reinforced by Strong TL1a Phase 2 Data and $3 Billion Duvakitug Peak Sales Outlook
7d ago
TEVA
Premium
The Fly
Teva and Sanofi’s duvakitug Phase 2b data shows efficacy in colitis and Crohn’s
8d ago
SNY
TEVA
Premium
The Fly
Teva price target raised to $45 from $36 at Goldman Sachs
16d ago
TEVA
Premium
Company Announcements
Teva’s Sustainability Disclosures Face Rising Legal and Investor Risk Amid Global Compliance Demands
21d ago
TEVA
Premium
The Fly
Teva price target raised to $38 from $35 at Barclays
26d ago
TEVA
Premium
The Fly
Teva price target raised to $40 from $35 at Scotiabank
27d ago
TEVA
Premium
Company Announcements
Teva Earnings Call: Innovation Offsets Generics and One-Offs
28d ago
TEVA
Premium
The Fly
Teva says targeting FY26 gross margin of 54.5%-55.5%
28d ago
TEVA
Premium
The Fly
Teva targets 2030 revenue mid-single digit CAGR
28d ago
TEVA
Premium
The Fly
Teva targets low-single digit revenue growth for FY27
28d ago
TEVA
Premium
The Fly
Teva says well-positioned to achieve 2030 financial targets
28d ago
TEVA
Premium
The Fly
Teva says ‘exciting growth’ emerging from biosimilar portfolio
28d ago
TEVA
Premium
The Fly
Teva sees FY26 adjusted EPS $2.57-$2.77, consensus $2.77
28d ago
TEVA
Premium
The Fly
Teva ‘continues to execute’ on pillars of ‘Pivot to Growth’ strategy
28d ago
TEVA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.